Quick Answer
Adagio Medical Holdings, Inc. reported Diluted EPS of $1.51 per share (loss) for fiscal year 2025.
Adagio Medical Holdings, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.51 | +96.9% |
| 2023 | -$48.16 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.66 | -3400.0% | -88.6% |
| June 30, 2025 | -$0.35 | +95.2% | +31.4% |
| March 31, 2025 | -$0.51 | +95.0% | -2650.0% |
| September 30, 2024 | $0.02 | +100.1% | +100.2% |
| July 31, 2024 | -$8.34 | +41.1% | -13.5% |
| June 30, 2024 | -$7.35 | — | +28.5% |
| March 31, 2024 | -$10.28 | — | +27.3% |
| September 30, 2023 | -$14.15 | — | +0.0% |
- Adagio Medical Holdings, Inc. showed an increase of +96.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, Adagio Medical Holdings, Inc.’s diluted eps has grown by 96.9% (from $48.16 per share (loss) to $1.51 per share (loss)).
- The most recent figure is from Adagio Medical Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: